文献速递妇科

卵巢癌患者十年条件生存概率:一种针对长期幸存者的新指标

Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors.
PubMed 文献 · Gynecol Oncol · 2022-12-13

本研究纳入2001年至2009年在本机构新诊断的高级别上皮性卵巢癌患者916例,评估条件生存概率(CPS)模型,计算已存活5年的患者再存活10年的概率。结果显示,<65岁5年幸存者的10年CPS为65%,≥65岁为48%;CPS较传统方法能更好预测长期幸存者的生存。

要点

  • 全部患者传统10年总生存率为29%(95% CI:26%-32%)。
  • <65岁5年幸存者的10年CPS为65%(95% CI:59%-70%)。
  • ≥65岁5年幸存者的10年CPS为48%(95% CI:38%-57%)。

核心结论

  • 对于高级别上皮性卵巢癌长期幸存者,CPS比传统方法能更好地预测生存。

研究设计与样本

  • 研究纳入2001年1月1日至2009年12月31日在本机构新诊断并治疗的高级别上皮性卵巢癌患者,排除随访<3年者,共916例。

主要发现

  • 全部患者传统10年总生存率为29%(95% CI:26%-32%),I/II期75%(95% CI:68%-82%),III期22%(95% CI:19%-26%),IV期6.9%(95% CI:3.9%-12%)。
  • <65岁5年幸存者的10年CPS为65%(95% CI:59%-70%),≥65岁为48%(95% CI:38%-57%)。
  • <65岁5年幸存者按分期的10年CPS:I/II期89%(95% CI:81%-94%),III期58%(95% CI:50%-66%),IV期26%(95% CI:12%-42%)。
  • ≥65岁5年幸存者按分期的10年CPS:I/II期78%(95% CI:53%-91%),III期42%(95% CI:30%-53%),IV期29%(95% CI:7%-56%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We assessed a conditional probability of survival (CPS) model to determine the probability of living 10 years after ovarian cancer diagnosis after having already survived 5 years. METHODS: We identified patients newly diagnosed with high-grade epithelial ovarian cancer from 1/1/2001-12/31/2009 and treated at our institution. Patients with <3 years follow-up were excluded. CPS was defined as the probability of surviving additional years (y) based on the condition a patient had already survived a given time (x): S(x + y)/S(x). Confidence intervals were estimated using a variation of Greenwood's formula. RESULTS: Of 916 patients meeting inclusion criteria, 473 (52%) were diagnosed from 2001 to 2005 and 443 (48%) from 2006 to 2009. Median age at diagnosis was 60 years (range, 25-95). The conventional 10-year OS rate for all patients was 29% (95% CI: 26%-32%)-75% (95% CI: 68%-82%) for stage I/II disease, 22% (95% CI: 19%-26%) for stage III, and 6.9% (95% CI: 3.9%-12%) for stage IV. For patients <65 years, the 10-year CPS for 5-year survivors was 65% (95% CI: 59%-70%); for those ≥65 years, it was 48% (95% CI: 38%-57%). For patients <65 years, the 10-year CPS for 5-year survivors by stage was: stage I/II, 89% (95% CI: 81%-94%); stage III, 58% (95% CI: 50%-66%); and stage IV, 26% (95% CI: 12%-42%). For patients ≥65 years, rates by stage were 78% (95% CI: 53%-91%), 42% (95% CI: 30%-53%), and 29% (95% CI: 7%-56%), respectively. CONCLUSIONS: For long-term survivors with high-grade epithelial ovarian cancer, CPS provides better prediction of survival than conventional methods.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Kahn R, Filippova O, Gordhandas S, et al. Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors. Gynecol Oncol. 2022. PMID: 36521353. doi:10.1016/j.ygyno.2022.11.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。